Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney.
Level 5 - mechanism / opinion, no new human data
Animal research in a rodent model (CEBM Level 5).
PubMed 8099476 · doi:10.1097/00000658-199306000-00007
What was done
Researchers evaluated glutamine metabolism across stages of progressive malignancy in rats implanted subcutaneously with non-metastasizing methylcholanthrene-induced (MCA) fibrosarcoma compared to pair-fed non-tumor-bearing controls. The investigation assessed hindquarter muscle glutamine release and blood flow, muscle glutamine concentrations, glutamine synthetase (GS) enzyme activity and mRNA expression, the response to dietary glutamine supplementation, and renal glutamine handling.
What was found
Tumor growth caused a twofold increase in hindquarter muscle glutamine release driven by a doubling of the fractional release rate without changes in blood flow, resulting in progressive skeletal muscle glutamine depletion. Muscle GS activity and mRNA expression initially increased more than twofold, but GS activity was no longer elevated in rats with large tumors and severe depletion. Dietary glutamine supplementation raised muscle glutamine concentrations and GS specific activity. Although tumor growth caused mild systemic acidemia, classic renal acidemic adaptations (elevated glutaminase and increased glutamine consumption) did not occur; instead, renal GS activity and ammoniagenesis increased despite reduced net renal glutamine uptake. Exact numerical values, variances, and animal counts were not reported in the abstract.
Why it matters
This work demonstrates how tumor burden alters host interorgan amino acid flow, showing that compensatory muscle glutamine synthesis fails to keep pace with tumor-driven systemic demand in advanced disease.
Limits
The study is limited to a non-metastasizing rat fibrosarcoma model, and the abstract omits sample sizes, exact baseline/endpoint numerical data, and statistical test metrics. Findings cannot be directly extrapolated to human cancer cachexia or other tumor types.
Cited by
- supports Cancer cachexia occurs when tumor cells mobilize and consume glutamine by breaking down host skeletal muscle.